Scaffold-Free 3D Stem Cell Tissue for Intervertebral Disc Engraftment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for intervertebral disc transplantation, such as those using scaffold-free self-organized 3D artificial tissues, face challenges with engraftment and durability of transplanted tissues.
Innovation Solution
An intervertebral disc therapeutic agent comprising a scaffold-free artificial tissue formed by synovium-derived mesenchymal stem cells, which are serum-free cultured and capable of forming a three-dimensional structure, enhances engraftment and durability at the transplantation site.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If scaffold-free self-organized 3D artificial tissue is used for intervertebral disc transplantation, then tissue strength for clinical application is achieved, but post-transplantation engraftment is insufficient
Solution Approach 1:
The invention changes the cell source parameter from adipose-derived mesenchymal stem cells to synovium-derived mesenchymal stem cells. This parameter change results in cells with enhanced engraftment capability while maintaining the ability to form scaffold-free 3D artificial tissue with sufficient mechanical strength for clinical application
Solution Approach 2:
The invention uses synovium-derived mesenchymal stem cells that naturally possess superior engraftment properties, effectively copying the favorable characteristics of synovial tissue cells to improve transplantation outcomes in intervertebral disc regeneration
Data Source
Figure 1
Figure 2~3
Figure 4
AI summary
Provided is an intervertebral disc therapeutic agent that exhibits favorable post-transplantation engraftment. The intervertebral disc therapeutic agent contains a scaffold-free artificial tissue in which synovium-derived mesenchymal stem cells have formed a three-dimensional structure.